Looking back, she wishes she would have sought out the answers before she got the combination vitamin and fat-dissolving shots
ARA-290 (Cibinetide) holds FDA Orphan Drug Designation for sarcoidosis-associated neuropathic pain but has not received marketing authorisation or clinical approval from the MHRA, FDA, EMA, or any regulatory authority for routine therapeutic use
While it may raise questions about water quality and safety, this issue typically points to a specific cause that can be addressed with the right water filtration system
Metabolic improvements The metabolic benefits observed in diabetes trials deserve attention independent of the neuropathy improvements
Surgery is more effective than nonoperative therapy in improving short- and long-term pain, especially if leg symptoms are predominant
HOPD and ASC Final Rule (CMS-1809-FC) 2025 NFRM Addendum B